Short Interest in Nuwellis, Inc. (NASDAQ:NUWE) Rises By 67.8%

Nuwellis, Inc. (NASDAQ:NUWE) saw a large increase in short interest in the month of January. As of January 31st, there was short interest totalling 558,100 shares, an increase of 67.8% from the January 15th total of 332,600 shares. Currently, 49.8% of the shares of the stock are sold short. Based on an average trading volume of 1,000,000 shares, the short-interest ratio is presently 0.6 days.

Institutional Investors Weigh In On Nuwellis

An institutional investor recently bought a new position in Nuwellis stock. Geode Capital Management LLC purchased a new stake in Nuwellis, Inc. (NASDAQ:NUWE) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 30,806 shares of the company’s stock, valued at approximately $34,000. Geode Capital Management LLC owned approximately 0.70% of Nuwellis as of its most recent SEC filing. 3.13% of the stock is owned by institutional investors and hedge funds.

Nuwellis Stock Down 1.6 %

Shares of NUWE stock opened at $1.21 on Thursday. Nuwellis has a fifty-two week low of $0.92 and a fifty-two week high of $27.61. The stock has a 50-day simple moving average of $1.17 and a 200 day simple moving average of $1.49. The stock has a market capitalization of $5.29 million, a P/E ratio of -0.01 and a beta of 0.31.

Nuwellis (NASDAQ:NUWE) last announced its quarterly earnings data on Monday, November 11th. The company reported $1.74 EPS for the quarter, beating analysts’ consensus estimates of ($0.88) by $2.62. The firm had revenue of $2.37 million for the quarter, compared to the consensus estimate of $2.40 million. Nuwellis had a negative net margin of 169.54% and a negative return on equity of 28,159.25%. During the same period in the previous year, the firm posted ($63.29) earnings per share. On average, sell-side analysts anticipate that Nuwellis will post -8.17 earnings per share for the current year.

Nuwellis Company Profile

Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.